Association of Serum Zinc and Selenium Concentration with Insulin Resistance in Apparently Healthy Adults

被引:0
作者
Fahad, Esraa Hammadi [1 ]
Hamdan, Farqad Bader [2 ]
Al-Mayah, Qasem Sharhan [3 ]
机构
[1] Mustansiriyah Univ, Coll Pharm, Dept Pharmacol & Toxicol, Baghdad, Iraq
[2] Al Nahrain Univ, Coll Med, Dept Physiol, Baghdad, Iraq
[3] Al Nahrain Univ, Coll Med, Dept Med Res Unit, Baghdad, Iraq
关键词
insulin resistance; zinc; selenium; LEVEL;
D O I
10.5937/afmnai42-52864
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Introduction/Aim. Zinc is a trace element involved in insulin metabolism, including its production, storage, and release. Selenium is regarded as a vital micronutrient for humans. It participates in insulin signaling and control. Zinc and selenium may be possibly linked to insulin resistance; however, these relationships have not been well investigated. Therefore, we sought to examine the relationship between blood zinc and selenium levels and insulin resistance in apparently healthy individuals. Methods. This study used a cross-sectional design including 203 apparently healthy people. Measurements were taken to determine zinc and selenium serum levels, fasting insulin, fasting blood glucose, and glycosylated hemoglobin. Insulin resistance was measured by utilizing the Homeostatic Model Assessment (HOMA-IR). Results. The prevalence of insulin resistance, as determined by HOMA-IR, was 26.11%. Patients with insulin resistance had higher age (59.96 +/- 12.28 years), body mass index (26.66 +/- 3.16 kg/m2), and waist-to-hip ratio (0.93 +/- 0.05) compared to those with insulin sensitivity (54.19 +/- 9.88 years, 25.92 +/- 2.4 kg/m2, 0.91 +/- 0.05), with statistically significant differences (p-values & horbar;0.013, 0.013, 0.029, respectively). Serum zinc levels were elevated in insulin-sensitive individuals (87.12 +/- 6.87 mcg/mL) compared to those who were insulin-resistant (84.05 +/- 8.29 mcg/mL), with a p-value of 0.036. HbA1c concentration and fasting insulin levels were elevated in the insulin-resistant group (4.95 +/- 0.49, 15.78 +/- 1.59) compared to the insulin-sensitive group (4.79 +/- 0.38, 10.1 +/- 2.34), with p-values of 0.033 and 0.003, respectively. Conclusion. In apparently healthy adults, there is an association between low serum zinc levels and insulin resistance. There is no association between selenium serum levels and insulin resistance.
引用
收藏
页码:74 / 84
页数:11
相关论文
共 31 条
[21]  
Maret Wolfgang, 2017, Prev Nutr Food Sci, V22, P1, DOI 10.3746/pnf.2017.22.1.1
[22]   Association between serum selenium level and the prevalence of diabetes mellitus in US population [J].
Moon, Shinje ;
Chung, Hye Soo ;
Yu, Jae Myung ;
Yoo, Hyung Joon ;
Park, Jung Hwan ;
Kim, Dong Sun ;
Park, Yoo-Kyung ;
Yoon, Sang Nam .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2019, 52 :83-88
[23]   Zinc deficiency affects insulin secretion and alters insulin-regulated metabolic signaling in rats [J].
Nakamura, Anna ;
Kido, Takamasa ;
Seki, Yoshiko ;
Suka, Machi .
JOURNAL OF TRACE ELEMENTS IN MEDICINE AND BIOLOGY, 2024, 83
[24]   Toenail selenium and cardiovascular disease in men with diabetes [J].
Rajpathak, S ;
Rimm, E ;
Morris, JS ;
Hu, F .
JOURNAL OF THE AMERICAN COLLEGE OF NUTRITION, 2005, 24 (04) :250-256
[25]   Zinc, zinc transporters and diabetes [J].
Rungby, J. .
DIABETOLOGIA, 2010, 53 (08) :1549-1551
[26]   Lipid-induced insulin resistance: unravelling the mechanism [J].
Samuel, Varman T. ;
Petersen, Kitt Falk ;
Shulman, Gerald I. .
LANCET, 2010, 375 (9733) :2267-2277
[27]   Autocrine effect of Zn2+ on the glucose-stimulated insulin secretion [J].
Slepchenko, Kira G. ;
Daniels, Nigel A. ;
Guo, Aili ;
Li, Yang V. .
ENDOCRINE, 2015, 50 (01) :110-122
[28]   The role of selenium in type-2 diabetes mellitus and its metabolic comorbidities [J].
Steinbrenner, Holger ;
Duntas, Leonidas H. H. ;
Rayman, Margaret P. P. .
REDOX BIOLOGY, 2022, 50
[29]   Zinc has an insulin-like effect on glucose transport mediated by phosphoinositol-3-kinase and AKT in 3T3-L1 fibroblasts and adipocytes [J].
Tang, XH ;
Shay, NF .
JOURNAL OF NUTRITION, 2001, 131 (05) :1414-1420
[30]   Oxidative stress as a therapeutic target in diabetes: revisiting the controversy [J].
Wiernsperger, NF .
DIABETES & METABOLISM, 2003, 29 (06) :579-585